CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Novo Nordisk Healthcare AG v. Laboratoire Francais du Fractionnement et des Biotechnologies S.A.

1:20-cv-00580

Overview

Case Number 1:20-cv-00580
Filing Date 2020-04-28
Status Terminated
Termination Date 2020-08-17
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Hema Biologics, LLC Operating Company

Represented By

4 Attorneys Listed

Ronald A. Lee

Email: ronaldlee@gibsondunn.com

Jane M. Love

Email: jlove@gibsondunn.com

Alexandra M. Joyce

McCarter & English, LLP

Tel: +1 (302) 984-6392
Fax: +1 (302) 450-4235

Renaissance Centre, 405 N. King Street, 8th Floor

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Laboratoire Francais du Fractionnement et des Biotechnologies S.A. Operating Company

Represented By

4 Attorneys Listed

Tiffany K. Sung

Email: tsung@foley.com

Stephen J. Kraftschik

Polsinelli PC

Tel: +1 (302) 252-0926
Fax: +1 (302) 252-0921

222 Delaware Avenue, Suite 1101, Wilmington, DE 19801

Michael R. Houston

Email: mhouston@foley.com

Jennifer L. Swize

Email: jswize@jonesday.com

Plaintiff

Novo Nordisk Inc. Operating Company

Represented By

2 Attorneys Listed

Brian P. Egan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9454

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Novo Nordisk Healthcare AG Operating Company

Represented By

2 Attorneys Listed

Brian P. Egan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9454

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 10 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (10): πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9102762
Virus filtration of liquid factor VII compositions
Filed: 2012-01-13
Issued: 2015-08-11
Expiring Soon (99 days)
Expires: 2027-02-27

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Narrowing Window β€” Imminent expiration makes injunctive relief unlikely to be granted.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

4

Dispositive

3

Granted

0

Denied

0

Pending / Review

4

Motions by Category

Procedural / Extension Motion 1 Motion to Dismiss (FRCP 12(b)(6)) 2 Motion to Dismiss 1

Key Dispositive Motions & Rulings

Motion to Dismiss Pending / Under Review
STIPULATION TO EXTEND TIME for plaintiffs to file their opposition to defendants' motion to dismiss (D.I. 14) to August 17, 2020 - filed by Novo Nordisk Healthc...
Entry #18 • 2020-07-13 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
MOTION to Dismiss for Failure to State a Claim 12(b)(6) and under Fed. R. Civ. P. 12(b)(1) for Lack of Subject Matter Jurisdiction - filed by Hema Biologics, LL...
Entry #14 • 2020-07-02 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
OPENING BRIEF in Support re 14 MOTION to Dismiss for Failure to State a Claim 12(b)(6) and under Fed. R. Civ. P. 12(b)(1) for Lack of Subject Matter Jurisdictio...
Entry #15 • 2020-07-02 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Defendants HEMA Biologics, LLC and Laboratoire Francais du Fractionnement et des Biotechnologies S.A. to answer or otherwise resp...
Entry #10 • 2020-05-20 Document →

Docket Entries

(20 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Hema Biologics, LLC, Laboratoire Francais du Fractionnement et des Biotechnologies S.A. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2909209.) - filed by Novo Nordisk Inc., Novo Nordisk Healthcare AG. (Attachments: # 1 Exhibit A-F, # 2 Civil Cover Sheet)(mal) (Entered: 04/28/2020)

Entry #1 • 2020-04-28
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) (Entered: 04/28/2020)

Entry #2 • 2020-04-28
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,102,762 B2. (mal) (Entered: 04/28/2020)

Entry #3 • 2020-04-28
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo Nordisk US Holdings Inc. for Novo Nordisk Inc.; Corporate Parent Novo Nordisk A/S for Novo Nordisk Healthcare AG. Novo Nordisk US Holdings Inc. is a privately held corporation wholly owned by Novo Nordisk A/S filed by Novo Nordisk Healthcare AG, Novo Nordisk Inc.. (mal) (Entered: 04/28/2020)

Entry #4 • 2020-04-28
1

Summonses Issued (please complete the top portion of the form and print out for use/service). (mal) (Entered: 04/28/2020)

Entry #5 • 2020-04-28
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc